Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
160M
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
83.5M
-
Shares change
-
+6.26M
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
+$101M
-
Put/Call ratio
-
1.68
-
Number of buys
-
119
-
Number of sells
-
-80
-
Price
-
$12.66
Significant Holders of NOVAVAX INC - Common Stock (NVAX) as of Q2 2024
297 filings reported holding NVAX - NOVAVAX INC - Common Stock as of Q2 2024.
NOVAVAX INC - Common Stock (NVAX) has 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.5M shares
of 160M outstanding shares and own 52.13% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14.1M shares), BlackRock Inc. (11.8M shares), SHAH CAPITAL MANAGEMENT (9.66M shares), D. E. Shaw & Co., Inc. (6.32M shares), STATE STREET CORP (6.07M shares), GEODE CAPITAL MANAGEMENT, LLC (3.2M shares), COATUE MANAGEMENT LLC (2.62M shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (2.11M shares), BANK OF MONTREAL /CAN/ (2.04M shares), and JANE STREET GROUP, LLC (1.88M shares).
This table shows the top 227 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.